Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mucosal metabolites fuel the growth and virulence of E. coli linked to Crohn’s disease
Shiying Zhang, Xochitl Morgan, Belgin Dogan, Francois-Pierre Martin, Suzy Strickler, Akihiko Oka, Jeremy Herzog, Bo Liu, Scot E. Dowd, Curtis Huttenhower, Matthieu Pichaud, Esra I. Dogan, Jack Satsangi, Randy Longman, Rhonda Yantiss, Lukas A. Mueller, Ellen J. Scherl, R. Balfour Sartor, Kenneth W. Simpson
Shiying Zhang, Xochitl Morgan, Belgin Dogan, Francois-Pierre Martin, Suzy Strickler, Akihiko Oka, Jeremy Herzog, Bo Liu, Scot E. Dowd, Curtis Huttenhower, Matthieu Pichaud, Esra I. Dogan, Jack Satsangi, Randy Longman, Rhonda Yantiss, Lukas A. Mueller, Ellen J. Scherl, R. Balfour Sartor, Kenneth W. Simpson
View: Text | PDF
Research Article Inflammation Microbiology

Mucosal metabolites fuel the growth and virulence of E. coli linked to Crohn’s disease

  • Text
  • PDF
Abstract

Elucidating how resident enteric bacteria interact with their hosts to promote health or inflammation is of central importance to diarrheal and inflammatory bowel diseases across species. Here, we integrated the microbial and chemical microenvironment of a patient’s ileal mucosa with their clinical phenotype and genotype to identify factors favoring the growth and virulence of adherent and invasive E. coli (AIEC) linked to Crohn’s disease. We determined that the ileal niche of AIEC was characterized by inflammation, dysbiosis, coculture of Enterococcus, and oxidative stress. We discovered that mucosal metabolites supported general growth of ileal E. coli, with a selective effect of ethanolamine on AIEC that was augmented by cometabolism of ileitis-associated amino acids and glutathione and by symbiosis-associated fucose. This metabolic plasticity was facilitated by the eut and pdu microcompartments, amino acid metabolism, γ-glutamyl-cycle, and pleiotropic stress responses. We linked metabolism to virulence and found that ethanolamine and glutamine enhanced AIEC motility, infectivity, and proinflammatory responses in vitro. We connected use of ethanolamine to intestinal inflammation and L-fuculose phosphate aldolase (fucA) to symbiosis in AIEC monoassociated IL10–/– mice. Collectively, we established that AIEC were pathoadapted to utilize mucosal metabolites associated with health and inflammation for growth and virulence, enabling the transition from symbiont to pathogen in a susceptible host.

Authors

Shiying Zhang, Xochitl Morgan, Belgin Dogan, Francois-Pierre Martin, Suzy Strickler, Akihiko Oka, Jeremy Herzog, Bo Liu, Scot E. Dowd, Curtis Huttenhower, Matthieu Pichaud, Esra I. Dogan, Jack Satsangi, Randy Longman, Rhonda Yantiss, Lukas A. Mueller, Ellen J. Scherl, R. Balfour Sartor, Kenneth W. Simpson

×

Figure 8

Mucosal metabolites fuel the growth and virulence of E. coli linked to Crohn’s disease.

Options: View larger image (or click on image) Download as PowerPoint
Mucosal metabolites fuel the growth and virulence of E. coli linked to C...
(A) In the healthy gut, resident AIEC can utilize a variety of mucus-derived substrates, including fucose and EA, for growth, with use of fucose/rhamnose linked to symbiosis. In the inflamed ileum, the mucosal niche of AIEC is characterized by loss of mucolytic Bacteroides and symbiont Firmicutes and culture of Enterococcus, oxidative stress, and an increase in metabolites associated with hypoxia and loss of barrier integrity. AIEC are better able to utilize regionally available EA than non-AIEC, and they cometabolize ileitis-associated amino acids and GSH to support metabolism of EA and resist stress in the inflamed and hypoxic mucosa. Sensing of regional metabolites may provide spatial awareness and induce chemotaxis to facilitate growth and mucosal association or translocation. In an IBD susceptible host, EA may enhance the ability of AIEC to induce inflammation. The ability of AIEC to resist environmental and metabolic stress in the inflamed intestine may precondition translocating AIEC for survival in macrophages. (B) Metabolic plasticity of AIEC is enabled by the eut and pdu MCP, glyoxylate shunt, methylcitrate pathway, pleiotropic stress responses, amino acid degradation, and γ-glutamyl-cycle. Sensing of amino acids, epinephrine, and ethanolamine modulates motility, chemotaxis, and biofilm formation.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts